Dr Reddy's Laboratories has expanded its consumer health offering with a UK product launch and US portfolio acquisition.
The Hyderabad, India-headquartered company has entered the UK OTC market with the launch of hay fever treatment Histallay
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?